Product
cytarabine
Aliases
cytosar-U
3 clinical trials
4 indications
Indication
Acute Myeloid LeukemiaIndication
RelapsedIndication
AdultClinical trial
A Safety and Tolerability Trial of Crenolanib and Chemotherapy With Cytarabine and Anthracyclines in Patients With Newly Diagnosed Acute Myeloid Leukemia With FLT3 Activating MutationsStatus: Completed, Estimated PCD: 2019-12-01
Clinical trial
A Phase I, Single-arm, Open Label, Dose Escalation, Multicenter Study of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)Status: Terminated, Estimated PCD: 2024-02-23